Executive function deficits in children with attention-deficit/hyperactivity disorder and improvement with lisdexamfetamine dimesylate in an open-label study.
about
Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescentsUpdate on optimal use of lisdexamfetamine in the treatment of ADHD.A pilot study of lis-dexamfetamine dimesylate (LDX/SPD489) to facilitate smoking cessation in nicotine-dependent adults with ADHDAssessing treatment outcomes in attention-deficit/hyperactivity disorder: a narrative reviewLisdexamfetamine in the treatment of adolescents and children with attention-deficit/hyperactivity disorder.The use of lisdexamfetamine dimesylate for the treatment of ADHD.Contribution of rating scales to intervention for executive dysfunction.Assessment of executive function in ADHD adolescents: contribution of performance tests and rating scales.The effects of lisdexamfetamine dimesylate on emotional lability in children 6 to 12 years of age with ADHD in a double-blind placebo-controlled trial.A Controlled Trial of Extended-Release Guanfacine and Psychostimulants on Executive Function and ADHD.
P2860
Q24186168-B3B46B0E-B41C-4B34-8A3C-19A11B9AB6E0Q30418053-AC71A075-3299-4A31-A1ED-8E663D844F96Q36170165-10D80BD0-C8E5-43D7-8DFE-E198536AF645Q36755295-F1ED8D07-CEA1-47E6-8B8E-D2F52014F959Q37561623-0EEAE036-3E2A-4B16-9175-BDD90459B414Q37975550-9C9EDA3A-D096-4FFD-A367-D70DD33B54ECQ38190120-4F2005E4-E6FC-4BE9-A635-A9531D36E28AQ48174539-ECAF632A-3274-4DAC-8794-E6196C8FF072Q48236410-D3C7E1E3-FE29-411D-AAA4-716E8F17ED44Q50127136-984C0893-BC51-4B64-AD66-DC47B2BA1800
P2860
Executive function deficits in children with attention-deficit/hyperactivity disorder and improvement with lisdexamfetamine dimesylate in an open-label study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Executive function deficits in ...... sylate in an open-label study.
@ast
Executive function deficits in ...... sylate in an open-label study.
@en
Executive function deficits in ...... sylate in an open-label study.
@nl
type
label
Executive function deficits in ...... sylate in an open-label study.
@ast
Executive function deficits in ...... sylate in an open-label study.
@en
Executive function deficits in ...... sylate in an open-label study.
@nl
prefLabel
Executive function deficits in ...... sylate in an open-label study.
@ast
Executive function deficits in ...... sylate in an open-label study.
@en
Executive function deficits in ...... sylate in an open-label study.
@nl
P2093
P2860
P356
P1476
Executive function deficits in ...... sylate in an open-label study.
@en
P2093
Atilla Turgay
Brian Scheckner
Bryan Dirks
Cynthia Richards
Elias Sarkis
Joseph Gao
Lawrence Ginsberg
Rakesh Jain
Robert L Findling
P2860
P304
P356
10.1089/CAP.2009.0110
P577
2010-12-01T00:00:00Z